174 related articles for article (PubMed ID: 26283963)
1. Targeting brain tumor cAMP: the case for sex-specific therapeutics.
Warrington NM; Sun T; Rubin JB
Front Pharmacol; 2015; 6():153. PubMed ID: 26283963
[TBL] [Abstract][Full Text] [Related]
2. The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.
Warrington NM; Sun T; Luo J; McKinstry RC; Parkin PC; Ganzhorn S; Spoljaric D; Albers AC; Merkelson A; Stewart DR; Stevenson DA; Viskochil D; Druley TE; Forys JT; Reilly KM; Fisher MJ; Tabori U; Allen JC; Schiffman JD; Gutmann DH; Rubin JB
Cancer Res; 2015 Jan; 75(1):16-21. PubMed ID: 25381154
[TBL] [Abstract][Full Text] [Related]
3. Intersections at the crossroads: Neurofibromatosis type 1, cAMP, sex, and glioma risk.
Rubin JB
Mol Cell Oncol; 2016 May; 3(3):e1069917. PubMed ID: 27314079
[TBL] [Abstract][Full Text] [Related]
4. Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.
Guo R; Liu T; Shasaltaneh MD; Wang X; Imani S; Wen Q
Front Oncol; 2022; 12():829212. PubMed ID: 35832555
[TBL] [Abstract][Full Text] [Related]
5. Increased Plasma Levels of Adenylate Cyclase 8 and cAMP Are Associated with Obesity and Type 2 Diabetes: Results from a Cross-Sectional Study.
Abdel-Halim SM; Al Madhoun A; Nizam R; Melhem M; Cherian P; Al-Khairi I; Haddad D; Abu-Farha M; Abubaker J; Bitar MS; Al-Mulla F
Biology (Basel); 2020 Aug; 9(9):. PubMed ID: 32847122
[TBL] [Abstract][Full Text] [Related]
6. Valproate activates phosphodiesterase-mediated cAMP degradation: relevance to C6 glioma G1 phase progression.
Gallagher HC; Bacon CL; Odumeru OA; Gallagher KF; Fitzpatrick T; Regan CM
Neurotoxicol Teratol; 2004; 26(1):73-81. PubMed ID: 15001216
[TBL] [Abstract][Full Text] [Related]
7. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
Dasgupta B; Dugan LL; Gutmann DH
J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
[TBL] [Abstract][Full Text] [Related]
8. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
Law PY; Loh HH
Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
[TBL] [Abstract][Full Text] [Related]
10. The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.
DeRubertis FR; Chayoth R; Field JB
J Clin Invest; 1976 Mar; 57(3):641-9. PubMed ID: 175089
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in SR Ca(2+) release in murine ventricular myocytes are regulated by the cAMP/PKA pathway.
Parks RJ; Ray G; Bienvenu LA; Rose RA; Howlett SE
J Mol Cell Cardiol; 2014 Oct; 75():162-73. PubMed ID: 25066697
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
13. Biphasic effect of cAMP-elevating agents on ICAM-1 expression stimulated by retinoic acid and interferon gamma.
Bouillon M; Fortier MA; Boulianne R; Audette M
Int J Cancer; 1992 Jan; 50(2):281-8. PubMed ID: 1370436
[TBL] [Abstract][Full Text] [Related]
14. Identification of phosphodiesterase IV activity and its cyclic adenosine monophosphate-dependent up-regulation in a human keratinocyte cell line (HaCaT).
Tenor H; Hatzelmann A; Wendel A; Schudt C
J Invest Dermatol; 1995 Jul; 105(1):70-4. PubMed ID: 7615979
[TBL] [Abstract][Full Text] [Related]
15. Oviduct cells express the cyclic AMP-adenosine pathway.
Cometti B; Dubey RK; Imthurn B; Jackson EK; Rosselli M
Biol Reprod; 2003 Sep; 69(3):868-75. PubMed ID: 12724271
[TBL] [Abstract][Full Text] [Related]
16. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1.
Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL
Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514
[TBL] [Abstract][Full Text] [Related]
17. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
[TBL] [Abstract][Full Text] [Related]
18. Evidence that parathyroid hormone-mediated calcium transport in rat brain synaptosomes is independent of cyclic adenosine monophosphate.
Fraser CL; Sarnacki P; Budayr A
J Clin Invest; 1988 Apr; 81(4):982-8. PubMed ID: 2832450
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclic-3',5'-nucleotide phosphodiesterase abrogates the synergism of hypoxia with lipopolysaccharide in the induction of macrophage TNF-alpha production.
Meng X; Ao L; Shames BD; Harken AH
J Surg Res; 2001 Dec; 101(2):210-5. PubMed ID: 11735278
[TBL] [Abstract][Full Text] [Related]
20. Modulation of corticotropin-releasing hormone stimulated cyclic adenosine monophosphate production by brain cells.
Kapcala LP; Aguilera G
Brain Res; 1995 Apr; 678(1-2):207-12. PubMed ID: 7620889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
